![](/img/cover-not-exists.png)
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
Francesca Bruzzese, Alessandra Leone, Monia Rocco, Carmine Carbone, Geny Piro, Michele Caraglia, Elena Di Gennaro, Alfredo BudillonVolume:
226
Year:
2011
Language:
english
Pages:
13
DOI:
10.1002/jcp.22574
File:
PDF, 3.82 MB
english, 2011